Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 8/20 | 0.62 |
| ▸ | HTR2A | P28223 | 3/20 | 0.62 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.62 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
| ▸ | HTR6 | P50406 | 3/20 | 0.58 |
| ▸ | HTR2C | P28335 | 1/20 | 0.58 |
| ▸ | DRD2 | P14416 | 1/20 | 0.55 |
| ▸ | DRD1 | P21728 | 1/20 | 0.55 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.52 |
| ▸ | HTR7 | P34969 | 1/20 | 0.49 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.48 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.48 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL659100 | 0.86 | TAAR1 (0.70) | TAAR1HTR2ALOXL2CYP2A6SMN1; SMN2 | |
| SCHEMBL26987876 | 0.84 | TAAR1 (0.63) | TAAR1HTR2ALOXL2CYP2A6SMN1; SMN2 | |
| SCHEMBL2459459 | 0.84 | HTR2A (0.80) | TAAR1HTR2ALOXL2CYP2A6SMN1; SMN2 | |
| SCHEMBL19313659 | 0.84 | CALM1 (0.60) | TAAR1HTR2ALOXL2CYP2A6SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL3957562 | 0.84 | TAAR1 (0.67) | TAAR1HTR2ALOXL2CYP2A6SMN1; SMN2 | |
| SCHEMBL13971231 | 0.83 | CALM1 (0.75) | LOXL2CALM1PRSS1PRSS2PRSS3 | |
| SCHEMBL7613502 | 0.83 | CALM1 (0.75) | LOXL2CALM1PRSS1PRSS2PRSS3 | |
| SCHEMBL922725 | 0.82 | LOXL2 (0.67) | TAAR1HTR2ALOXL2SMN1; SMN2HTR6 | |
| SCHEMBL2642524 | 0.79 | TAAR1 (0.61) | TAAR1HTR2ALOXL2CYP2A6SMN1; SMN2 | |
| SCHEMBL5543556 | 0.78 | CALM1 (0.52) | LOXL2CALM1PRSS1PRSS2PRSS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4619017-A1 | ANTIBIOTIC-RESISTANT BACTERIA | Imperial College Innovations Limited (GB) | 2025-09-24 | — | — | EP | disclosed |
| WO-2024105412-A1 | ANTIBIOTIC-RESISTANT BACTERIA | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2024-05-23 | — | — | WO | disclosed |
| EP-2318126-B1 | WATER PURIFICATION MEMBRANES WITH IMPROVED FOULING RESISTANCE | UNIV TEXAS (US) | 2018-08-22 | — | — | EP | disclosed |
| US-8017050-B2 | Water purification membranes with improved fouling resistance | BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM (US) | 2011-09-13 | — | — | US | disclosed |
| EP-2318126-A2 | WATER PURIFICATION MEMBRANES WITH IMPROVED FOULING RESISTANCE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2011-05-11 | — | — | EP | disclosed |
| WO-2011005258-A1 | POLYMER DEPOSITION AND MODIFICATION OF MEMBRANES FOR FOULING RESISTANCE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2011-01-13 | — | — | WO | disclosed |
| US-20100059433-A1 | POLYMER DEPOSITION AND MODIFICATION OF MEMBRANES FOR FOULING RESISTANCE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2010-03-11 | — | — | US | disclosed |
| US-20100051538-A1 | WATER PURIFICATION MEMBRANES WITH IMPROVED FOULING RESISTANCE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2010-03-04 | — | — | US | disclosed |
| WO-2010006196-A2 | WATER PURIFICATION MEMBRANES WITH IMPROVED FOULING RESISTANCE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2010-01-14 | — | — | WO | disclosed |
| US-7268166-B2 | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases | NPS PHARMACEUTICALS, INC. (US) | 2007-09-11 | — | — | US | disclosed |
| US-5480871-A | TREATMENT OF BENIGN PROSTATIC HYPERPLASIA | CHIRON CORPORATION (US) | 1996-01-02 | — | — | US | disclosed |
| WO-1995027729-A1 | OPIATE RECEPTOR LIGANDS | CHIRON CORPORATION (US) | 1995-10-19 | — | — | WO | disclosed |
| EP-0671928-A1 | SYNTHESIS OF N-SUBSTITUTED OLIGOMERS | CHIRON CORPORATION (US) | 1995-09-20 | — | — | EP | disclosed |
| US-5447916-A | Hypotensive agents | CHIRON CORPORATION (US) | 1995-09-05 | — | — | US | disclosed |
| EP-0647230-A1 | CEPHALOSPORINS AND 1-CARBA-1-DETHIA CEPHALOSPORINS | PFIZER INC. (US) | 1995-04-12 | — | — | EP | disclosed |
| WO-1995004072-A1 | PEPTOID ALPHA-1 ADRENERGIC RECEPTOR LIGANDS | CHIRON CORPORATION (US) | 1995-02-09 | — | — | WO | disclosed |
| EP-0624160-A1 | 2-ISOCEPHEM AND OXACEPHEM DERIVATIVES, PROCESSES FOR THEIR PREPARATION, INTERMEDIATES THEREOF AND USE AS ANTIBACTERIAL AGENTS | PFIZER INC. (US) | 1994-11-17 | — | — | EP | disclosed |
| WO-1994006451-A1 | SYNTHESIS OF N-SUBSTITUTED OLIGOMERS | CHIRON CORPORATION (US) | 1994-03-31 | — | — | WO | disclosed |
| WO-1994000457-A1 | ALPHALOSPORINS AND 1-CARBA-1-DETHIA CEPHALOSPORINS | SMITHKLINE BEECHAM P.L.C. (GB) | 1994-01-06 | — | — | WO | disclosed |
| WO-1993015085-A1 | 2-ISOCEPHEM AND OXACEPHEM DERIVATIVES, PROCESSES FOR THEIR PREPARATION, INTERMEDIATES THEREOF AND USE AS ANTIBACTERIAL AGENTS | SMITHKLINE BEECHAM PLC (GB) | 1993-08-05 | — | — | WO | disclosed |